Related Experiment Video
Updated: Dec 2, 2025
11:28
Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus
Published on: October 7, 2011
11.3K
Pathogenesis of Human Gammaherpesviruses: Recent Advances
Darin J Weed1, Blossom Damania1
1Lineberger Comprehensive Cancer Center and Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC 27514, USA.
Current Clinical Microbiology Reports
|November 2, 2020
Summary
Recent research illuminates human gammaherpesvirus lifecycles, focusing on Epstein-Barr virus (EBV) and Kaposi
Area of Science:
- Virology
- Immunology
- Oncology
Background:
- Human gammaherpesviruses, including Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV), are linked to numerous global cancers.
- Currently, no FDA-approved vaccines exist for KSHV or EBV, highlighting a critical unmet medical need.
- Understanding viral lifecycles is key to developing effective therapeutic strategies against these pathogens.
Purpose of the Study:
- To review recent advancements in comprehending the lifecycles of EBV and KSHV during human infection.
- To highlight key host and viral factors contributing to the pathogenesis of these gammaherpesviruses.
- To summarize findings from the past five years concerning viral persistence and replication mechanisms.
Main Methods:
- This review synthesizes recent scientific literature.
- Focuses on studies investigating viral latency, reactivation, and replication.
- Examines the role of non-coding RNAs and host-viral interactions.
Main Results:
- Establishment of viral latency is a critical area of research, with non-coding RNAs playing a significant role.
- Innate immune antagonism is a major factor restricting viral reactivation from latency.
- Novel host proteins involved in the lytic replication cycle of these viruses have been identified.
Conclusions:
- Recent findings have significantly advanced our understanding of EBV and KSHV pathogenesis.
- The interplay between host factors and viral mechanisms is crucial for viral persistence and disease development.
- Continued research into these complex lifecycles is essential for future therapeutic and vaccine development.
Related Concept Videos
00:36Viral Mutations
38.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
38.3K
02:33Retroviruses
13.9K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
13.9K
01:51Mechanisms of Retrovirus-induced Cancers
6.3K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.3K